Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
ICAS calls for clearer safeguards in FRC’s TCA policy - 26 Web-based Lawful Administrations: Extensive Surveys and Elements
- 3HGV driver recruited others to smuggle migrants
- 4Obamacare enrollment declines as US subsidies expire
- 5'Not the moon that I'm used to seeing': Artemis II astronauts describe seeing the far side
- NASA counts down for first crewed lunar mission in half a century
- Gaza Strip sees flooding after heavy rainfall
- Affordable Care Act enrollment is slightly ahead of last year, despite expiring subsidies
- South Carolina's measles outbreak reaches 434 cases
- EU chief urges Iran to free imprisoned protesters, lift internet ban
- Putin critic gets six years in penal colony, vows hunger strike
- Major Scottish gangland figure Steven Lyons arrested in Bali
- The Tradition of Stone: A Gander at Notable Structures Through the Ages
- Mexico says a third of 130,000 missing people might be alive, fueling criticisms by families
